Drug Type Small molecule drug |
Synonyms BIA-5-1058 |
Target |
Mechanism DBH inhibitors(Dopamine beta-hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC21H21F2N3OS |
InChIKeyZSSLCFLHEFXANG-GOSISDBHSA-N |
CAS Registry1080028-80-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Arterial Hypertension | Phase 2 | ES | 06 Jun 2019 | |
Heart Failure | Phase 1 | GB | 09 Apr 2018 | |
Chronic heart failure | Phase 1 | NL | 01 Mar 2011 | |
Hypertension | Phase 1 | NL | 01 Mar 2011 |
Not Applicable | - | 44 | rshsosnzxp(nzqlchcxwv) = xshflwxnaa lplrcplvom (kshyrlhvdg, 94 - 108) View more | - | 05 Sep 2021 | ||
rshsosnzxp(nzqlchcxwv) = pomoholdol lplrcplvom (kshyrlhvdg, 64 - 87) View more | |||||||
Not Applicable | - | 20 | mplzttnbrn(dubigepskp) = umalmfawgp yrxpdjqiry (gzhxolulhz, 79 - 111) View more | - | 07 Sep 2020 | ||
mplzttnbrn(dubigepskp) = yplkdicfpt yrxpdjqiry (gzhxolulhz, 89 - 107) View more |